USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.02% | -384.52% | 523.38% | 72.78% | -167.55% |
| Total Depreciation and Amortization | 5.42% | -6.32% | -4.83% | 7.52% | -0.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.78% | 254.91% | 0.72% | 5.89% | 330.87% |
| Change in Net Operating Assets | -67.82% | 194.55% | 23.72% | -66.28% | -144.25% |
| Cash from Operations | -48.69% | 138.95% | 387.88% | -72.87% | -116.05% |
| Capital Expenditure | -11.63% | -19.28% | 5.37% | 12.60% | 36.38% |
| Sale of Property, Plant, and Equipment | -80.00% | -68.75% | -98.77% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -100.00% |
| Cash from Investing | 13.26% | -56.22% | -333.96% | 134.71% | 23.16% |
| Total Debt Issued | -100.00% | 25.00% | -75.00% | -- | -100.00% |
| Total Debt Repaid | 100.00% | -375.00% | -100.00% | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -253.85% | 98.85% | -3,944.64% | 44.00% | 99.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -180.24% | 44.14% | -131.93% |
| Cash from Financing | 99.34% | -285.22% | -127.06% | 1,474.16% | 97.46% |
| Foreign Exchange rate Adjustments | 230.89% | -31.36% | -53.19% | 1,060.00% | -92.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.56% | 32.47% | -66.25% | 319.10% | 78.85% |